SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-051443
Filing Date
2024-05-01
Accepted
2024-05-01 18:07:55
Documents
1
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5066
  Complete submission text file 0000950170-24-051443.txt   6727
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ASSEMBLY BIOSCIENCES, INC. 99 HUDSON STREET, 5TH FLOOR NEW YORK NY 10013
Business Address
Small Derek A (Reporting) CIK: 0001613260 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 24904432